Literature DB >> 7933148

Intravirion reverse transcripts in the peripheral blood plasma on human immunodeficiency virus type 1-infected individuals.

H Zhang1, O Bagasra, M Niikura, B J Poiesz, R J Pomerantz.   

Abstract

Variable levels of viral DNA have been demonstrated within human immunodeficiency virus type 1 (HIV-1) virions purified from cell cultures. In the present studies, it is demonstrated that DNase-resistant viral DNA is associated with HIV-1 virions purified from the peripheral blood plasma of both symptomatic and asymptomatic HIV-1-infected individuals. The differences in viral DNA copy numbers, detected by quantitative PCR in various regions of the HIV-1 genome, indicated that the intravirion HIV-1 DNA is frequently, but perhaps not totally, the result of partial reverse transcription. These in vivo data suggest that it may be valuable to further investigate the impact of virion-associated viral DNA upon the efficiency of intra- and interhost HIV-1 transmission modes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933148      PMCID: PMC237208     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Kinetics of synthesis, structure and purification of avian sarcoma virus-specific DNA made in the cytoplasm of acutely infected cells.

Authors:  H E Varmus; S Heasley; H J Kung; H Oppermann; V C Smith; J M Bishop; P R Shank
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.

Authors:  J Mulder; N McKinney; C Christopherson; J Sninsky; L Greenfield; S Kwok
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

4.  Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms.

Authors:  J A Levy; J Shimabukuro; H Hollander; J Mills; L Kaminsky
Journal:  Lancet       Date:  1985-09-14       Impact factor: 79.321

5.  Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome.

Authors:  L S Fujikawa; S Z Salahuddin; A G Palestine; H Masur; R B Nussenblatt; R C Gallo
Journal:  Lancet       Date:  1985-09-07       Impact factor: 79.321

6.  HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.

Authors:  J E Groopman; S Z Salahuddin; M G Sarngadharan; P D Markham; M Gonda; A Sliski; R C Gallo
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

7.  A sensitive viral capture assay for detection of plasma viremia in HIV-infected individuals.

Authors:  D R Henrard; W F Mehaffey; J P Allain
Journal:  AIDS Res Hum Retroviruses       Date:  1992-01       Impact factor: 2.205

8.  Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses.

Authors:  D Trono
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

9.  HTLV-III in the semen and blood of a healthy homosexual man.

Authors:  D D Ho; R T Schooley; T R Rota; J C Kaplan; T Flynn; S Z Salahuddin; M A Gonda; M S Hirsch
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  28 in total

1.  Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

Authors:  T Pierson; T L Hoffman; J Blankson; D Finzi; K Chadwick; J B Margolick; C Buck; J D Siliciano; R W Doms; R F Siliciano
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  In vitro synthesis of long DNA products in reactions with HIV-RT and nucleocapsid protein.

Authors:  Reshma M Anthony; Jeffrey J Destefano
Journal:  J Mol Biol       Date:  2006-10-06       Impact factor: 5.469

3.  Impact of human immunodeficiency virus type 1 RNA dimerization on viral infectivity and of stem-loop B on RNA dimerization and reverse transcription and dissociation of dimerization from packaging.

Authors:  N Shen; L Jetté; C Liang; M A Wainberg; M Laughrea
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.

Authors:  H Zhang; G Dornadula; P Alur; M A Laughlin; R J Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

Review 5.  Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

Authors:  M Clementi; S Menzo; P Bagnarelli; A Valenza; S Paolucci; R Sampaolesi; A Manzin; P E Varaldo
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Highly purified CD25- resting T cells cannot be infected de novo with HIV-1.

Authors:  C S Chou; O Ramilo; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

7.  HIV-1 protease inhibits its homologous reverse transcriptase by protein-protein interaction.

Authors:  M Böttcher; F Grosse
Journal:  Nucleic Acids Res       Date:  1997-05-01       Impact factor: 16.971

8.  Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection.

Authors:  Theodore C Pierson; Yan Zhou; Tara L Kieffer; Christian T Ruff; Christopher Buck; Robert F Siliciano
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Expression of human immunodeficiency virus type 1 reverse transcriptase in trans during virion release and after infection.

Authors:  M A Ansari-Lari; R A Gibbs
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.

Authors:  F Shaheen; L Duan; M Zhu; O Bagasra; R J Pomerantz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.